X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

    Key Areas For AI/ML Drug Development – FDA Discussion Paper

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Rising Pharmaceuticals Demand Drives Tablet Coatings Market

    Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

    Particle Size Distribution Real-Time Monitoring With PEACE

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

    Key Areas For AI/ML Drug Development – FDA Discussion Paper

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

    Rising Pharmaceuticals Demand Drives Tablet Coatings Market

    Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

    Particle Size Distribution Real-Time Monitoring With PEACE

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

    Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operation

Content Team by Content Team
7th December 2022
in Manufacturing, Middle East and South Asia, Press Statements
Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza. Fraunhofer IZI will use Lonza’s MODA-ES® to facilitate its transition from an entirely paper-based, manual documentation process to an automated, fully electronic GMP-compliant system.
 
Manufacturing cell and gene therapies — advanced therapy medicinal products — requires extensive documentation of all manufacturing and verification steps to ensure patient safety and GMP compliance. For organizations with complex workflows, selecting the right electronic batch record solution is critical.

Dr. Gerno Schmiedeknecht, Head of the Department GMP Cell and Gene Therapy, Fraunhofer IZI, commented: “With the introduction of fully electronic batch documentation, manufacturing and batch release for our customers and partners will be even safer, faster, more cost-effective and generally more efficient. In addition, this measure leads to higher flexibility in a potential pandemic situation, as the process of reviewing the batch documentation and the batch release, in particular, can largely be carried out in remote mode without direct onsite presence.”

David McErlane, SVP, Head of Bioscience, Lonza, added: “We are excited to support Fraunhofer IZI with their MODA-ES® Implementation. Electronic batch records have been unattainable to most of the industry due to cost constraints and flexibility concerns. With a deep understanding of the challenges faced by cell and gene manufacturers, we designed MODA-ES® with the end user in mind to provide a cost-effective and usable solution that meets our customers’ requirements.”

The MODA® Platform bridges the gap between manufacturing and quality control, providing a mechanism to produce a single electronic batch record. Lonza’s manufacturing and lab execution software enables data capture and provides workflow and analytical tools to expedite product release. With a focus on a user-centric, scalable solution that may be implemented in an accelerated timeline, the MODA® Platform supports customers in their efforts to realize their digitalization goals.

Previous Post

Could The New 3D Substances Enhance The Delivery of Drugs?

Next Post

Addressing Cholestatic Liver Disease Upon Cognitive Decline

Related Posts

Manufacturing

Pharma Adopts Digitalization For Improved Drug Manufacturing

19th May 2023
Manufacturing

Sandoz, Evotec Launch AI-Driven Biosimilar Manufacturing

18th May 2023
Recipharm supports FDA approval of Perrigos AB-rated generic product
Drug Development

FDA approves the manufacture of new microbiome-based therapeutic VOWSTTM at Recipharm site

8th May 2023
Manufacturing

EU States Seek Reduced Reliance On Chinese Pharma Imports

4th May 2023
Press Statements

Aptar Digital Health and Healint Announce Innovative Collaboration for Central Nervous System and Immune System Conditions

25th April 2023
Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Next Post
Elsevier and FDA to work on AI algorithm for drug-induced liver injury

Addressing Cholestatic Liver Disease Upon Cognitive Decline

Latest News

IPR Data Management

Machine Learning – A Game-Changer In The Pharma Industry

26th May 2023
IPR Data Management

Impact of AI On The Pharmaceutical Industry Sparks Debates

26th May 2023
IPR Data Management

Advancing Pharma Logistics – Smart Contracts And Blockchain

25th May 2023
Facilities & Operation

Switzerland Emerges As The Headquarters For European Biotech

25th May 2023
News

Genomics Market Growth In India To Accelerate Affordability

24th May 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In